Background/Aims: Autophagy, an evolutionary conserved biological process, is activated in cells to cope with various types of stress. MicroRNAs control several activities related to autophagy. However, the role of autophagy-related microRNAs during atherosclerosis is far from known. MicroRNA-155 was identified to be a crucial regulator of atherosclerosis. The objectives of the study were to analyze the effect of microRNA-155 on autophagic signaling and explore its mechanism in human endothelial cells under ox-LDL stress. Methods: The study included human endothelial cells surrogate EA.hy926 lines (EA.hy926 cells). The expression of microRNA-155 was analyzed by quantitative reverse transcription polymerase chain reaction (qRT-PCR). The effect of microRNA-155 on endothelial autophagy was observed along with the expression levels of Rheb, LC3B, Beclin1, and P62/SQSTM1 by western blotting (WB) and immunofluorescence through microRNA-155 overexpression or inhibition. Bioinformatics analysis and Luciferase reporter assay were used to explore the target gene of microRNA-155. Cell viability and apoptosis were examined by 3-[4,5-dimethylthiazol-2-yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium inner salt (MTS) assay and TdT-mediated dUTP Nick-End Labeling (TUNEL) apoptosis assay. Results: MicroRNA-155 expression was significantly increased under ox-LDL stress. MicroRNA-155 increased autophagic activity, while inhibition of it alleviated ox-LDL-induced autophagy in EA.hy926 endothelial cells. In addition, dual-luciferase reporter assays showed that microRNA-155 suppressed Rheb transcription. MicroRNA-155 increased autophagic activity in EA.hy926 cells via inhibition of Rheb-mediated mTOR/P70S6kinase/4EBP signaling pathway. Furthermore, we demonstrated that microRNA-155 could regulate not only autophagy but also apoptosis in EA.hy926 cells. Conclusions: MicroRNA-155 works as a regulator of endothelial function under ox-LDL stress, making it a potential candidate for the novel therapeutic strategies against atherosclerotic diseases.
Introduction
Atherosclerosis continues to be the leading cause of morbidity and mortality worldwide [1] . The key cellular mechanisms underlying atherosclerosis include hyperlipidemia, induced inflammation, phenotypic changes in smooth-muscle cells (SMCs) and endothelial dysfunction [2] . Accumulating evidence suggests that the endothelial dysfunction caused by vascular injury appears to be an causative initiating event in atherosclerosis [3] . Meanwhile, it was found that the endothelial function regulators are vital in mediating autophagy in atherosclerosis.
Autophagy is an evolutionary conserved cellular catabolic process that delivers cytoplasmic materials to the lysosome for degradation in eukaryotic cells [4] . It plays an important role in the degradation of damaged organelles and extra biological molecules for reconstruction of the cellular structure [5] . Successful autophagy assists, in the progression of cytogenesis, in cell survival and protects cell from dysfunction [6] . Nevertheless, highly activated autophagy conversely destroys major proportions of cell organelles, and may even lead to autophagic cell death (type II programmed cell death) [7, 8] . Recent studies uncovered the underlying mechanism of autophagy, triggered by oxidized lipids, pro-inflammation factors, and metabolic stress conditions in controlling diverse cardiovascular functions [9, 10] . Similar to the process of apoptosis, autophagy is also a multistage progression that is subjected to gene regulation under some physiologic or pathologic circumstances [11] .
MicroRNAs (miRNAs, MIRs) are a family of short non-coding RNA molecules, which modulate gene expression by post-transcriptional regulation, and result in either translation inhibition or RNA degradation [12] . These small molecules are generally expressed abundantly in normal tissues, and are often dysregulated in several diseases [13, 14] . MicroRNA-155 (MIR-155) is a typical multi-functional microRNA, which is highly expressed in atherosclerotic lesions [15] . It was reported that microRNA-155 takes part in the formation of foam cell by targeting HBP1 and Bcl6, which consecutively enhance inflammatory response in atherosclerosis. The underlying mechanism involves the activation of NF-κB signaling via targeting SOCS1, which in turn increases tumor necrosis factor-α(TNF-α) translation, and decreases endothelial nitric oxide synthase (eNOS) expression in endothelial cells [16] [17] [18] [19] . Nevertheless, contradictory results exist with regard to the protective nature of microRNA-155 in atherosclerosis. It was demonstrated that microRNA-155 acts as an antiinflammatory factor by repressing calcium-regulated heat stable protein-1 and NF-κB p65 to suppress endothelial injury [20, 21] . Anyhow, these previous findings coincide with our results which identified that microRNA-155 is significantly up-regulated following exposure of endothelial cells to ox-LDL, and correlates with atherosclerosis.
The regulatory role of microRNAs in cellular autophagy has been validated since 2009 [22] . In recent years, microRNA-155 has been paid more attention in autophagic processes. For example, Wang et al. illustrated that microRNA-155 enhances autophagy-mediated mycobacterial elimination in macrophages [23] . Chen et al. reported that microRNA-155 activates autophagy in osteosarcoma cells, and then ameliorates the anticancer drug-induced cell proliferation [24] . Moreover, several studies have showed that microRNA (miRNA)-based therapeutics could limit off-target effects and emerge as novel therapeutic agents in various human diseases [25, 26] . However, the effect of microRNA-155 on autophagy in endothelial cells and its mechanism still remains unknown. Hence, in the present study, we investigated the role of microRNA-155 in autophagy regulation in EA.hy926 endothelial cells to find out new remedy for atherosclerosis and other vascular diseases.
Materials and Methods

Cell culture and treatment
Human endothelial cells surrogate EA.hy926 lines (EA.hy926 cells) were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Cells were cultured as routine in Dulbecco's Modified Eagle's high glucose medium (DMEM) (Biological Industries, 01-054-1A) supplemented with 10% inactivated fetal bovine serum (Biological Industries, 03-031-1B) and 10U/ml penicillin-streptomycin (Biological Industries, 04-001-1A) in a 5% CO 2 -humidified incubator at 37°C. Cells at 60% confluence were activated by oxidized-LDL (ox-LDL), (Yiyuanbiotech Ltd, YB-002).
Target prediction
The conventional online programs, including Targetscan (http://www. targetscan.org), PicTar (http:// pictar.mdc-berlin.de/) and miRanda (http: //www. microrna.org/microrna/ home. do) were used to predict the targets of microRNA-155. The targets predicted by these programs were further analyzed and demonstrated by the biological experiments. 
RNA transfection
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
Total RNA was isolated using Eastep TM total RNA extraction kit (Promage, Shanghai LS1030). We performed qRT-PCR analyses for mRNA using TransScript green one-step qRT-PCR kit (Transgen biotech, AQ211-01). GAPDH was used as an internal reference control. We performed qRT-PCR analyses for microRNA-155 using Hairpin-it TM microRNA and U6 snRNA normalization RT-PCR quantitation kit (GenePharma, E22002) in an ABI 7500 fast system (applied biosystems CA, USA). In short, 2mg total RNAs were reverse transcribed to cDNA, then qPCR was performed using specific primer set to examine expression of mRNAs and microRNA-155. The qRT-PCR results were calculated using the comparative threshold cycle (Ct) method. Specific primers used in the present study are as follows: has-microRNA-155, sense 5'-TAATGCTAATCGTGATAGGG-3', antisense 5'-TTTGGCACTAGCAC ATT-3'; U6 snRNA, sense 5'-CTCGCT TCGGCAGCACA-3', antisense 5'-AACGCTTCACGAATTTG CGT-3'; mTOR, sense 5'-AGGCCGCATTGTCTCTATCAA -3', antisense 5'-GCAGTAAATGCAGGTAGTCATCCA-3'; GAPDH: sense 5'-CCAGAACATCATCCCTGC-3', antisense 5'-GGAAGGCCATGCC AGTGAGC-3'.
Construction of luciferase plasmids and reporter assay
The 3'untranslated region (UTR) of Rheb fragment containing putative binding sites for microRNA-155 was amplified by PCR from human genomic DNA and cloned into pRL-TK reporter vector (Promega, E2241). The predicted target site was mutated by site-directed mutagenesis. For luciferase reporter assays, the wildtype (WT) or mutated (MUT) luciferase plasmids and microRNAs were co-transfected into cells and each experiment was repeated in triplicate. Cells were lysed at 30h post-transfection and luciferase activities were assayed by a dual-Luciferase Reporter System (Promega, E1960). Firefly luciferase activity was normalized to Renilla luciferase activity, with ratios of firefly luciferase vlaues/renilla.
Western blot
Cells were lysed in ice-cold radio immunoprecipitation assay (RIPA) lysis buffer (Byotime Ltd, P0013B), supplemented with Phenylmethanesul-fonyl (PMSF) (Byotime Ltd, ST-506). Total protein concentration of cell lysate was detected using BCA protein assay (Byotime Ltd, P0010) at 562nm on a spectrophotometer (Thermo Scientific). Cell extracts were resolved by sodium dodecyl sulfate-polyacrylamide gel electropheresis (SDS-PAGE). Antibodies used for western blotting were as follows: MAP1LC3B ( Cell staining for immunofluorescence microscopy Transfected EA.hy926 cells were fixed with 4% paraformaldehyde for 15 min and blocked with 3% goat serum for 20 min at room temperature, then incubated with Beclin-1 antibody (1:100 Proteintech, 18725-1-AP) for overnight at 4°C. The next day, cells were washed in 0.1mol/L phosphate buffered saline (PBS) for 3 times and then incubated with fluorescein-conjugated affinipure goat anti-rabbit IgG (1:200 Proteintech, SA00003-2) for 1 hour at 37°C and subsequently stained the nuclei with DAPI. Finally, cells were observed using an Olympus BX51 fluorescence microscope (Tokyo, Japan). / well for 12h. Then the medium was discarded, and cells were washed twice with PBS. Fresh medium containing 10% MTS (Promega, G3582) reaction solution was added into each well, and spectrophotometric absorbance was determined after 4h at OD490 .
Cell viability assay
Flow cytometry analysis
Apoptosis was examined using the TUNEL (TdT-mediated dUTP Nick-End Labeling) apoptosis detection kit (Roche, Mannheim, Germany) to monitor the DNA fragmentation and analyzed by a FAC Scanflow cytometer (BD, USA) in accordance with the manufacturer's instructions.
Statistical analyses
Statistical analyses were performed using SPSS 17.0 software (SPSS Inc.). The significance of differences observed in samples was determined using Student's 2-tailed t-test or one-way ANOVA. All quantitative results were shown as means±standard deviation (SD) of at least 3 independent experiments. Values of P < 0.05 were considered to be statistically significant.
Results
Ox-LDL induces microRNA-155 up-regulation in endothelial cells
Ox-LDL is a pivotal atherogenic inducer in endothelial activation [27] . To investigate the function of microRNA-155 in endothelial autophagy, we initially detected the expression of microRNA-155 in EA.hy926 endothelial cells under ox-LDL stress. Cells were stimulated by ox-LDL at various concentrations (0, 10, 20, 40 and 80μg/ml) for 24 hours or at different times (0, 6, 12, 24, and 48h) at a concentration of 80μg/ml. As shown, ox-LDL stimulation induced significant microRNA-155 up-regulation in time and dose-dependent manner (Fig.  1A -B, **P<0.01).
MicroRNA-155 induces autophagy in endothelial cells
To regulate microRNA-155 expression in EA.hy926 endothelial cells, we transfected microRNA-155 mimics or inhibitor into EA.hy926 endothelial cells for 24h, and qRT-PCR was applied to evaluate the transfection efficiency. The results revealed that microRNA-155 expression was significantly higher in microRNA-155 mimic group and lower in microRNA-155 inhibitor group compared with their respective negative controls (NC) and blank groups ( Fig. 2A-B , ***P < 0.001). But no significant differences were observed between Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry negative control and blank groups. Besides, FAM fluorescence labeling indicated that more than 90% of cells treated with either the mimics or inhibitor oligos were transfected. (Fig.  2C) .
To explore the role of microRNA-155 in autophagy, we detected microtubule associated protein 1 light chain 3-I/light chain 3-II (LC3I/LC3II) and Beclin-1 levels by western blot (WB), which have been long recognized as two crucial autophagic vacuole markers [28] . Results demonstrated that microRNA-155 led to a significant increase of LC3-II and Beclin-1 levels ( Fig. 2D and G, **P<0.01). To further demonstrate the results, we observed the effects (Fig.  2F) . Thus, both results suggest that microRNA-155 induces autophagosome accumulation in EA.hy926 endothelial cells. However, the autophagosome accumulation attributes to either enhanced autophagic activation or a block in the downstream degradation [29] . The autophagic flux should be analysed in EA.hy926 endothelial cells. First, we examined the protein level of P62/SQSTM1 by western blot, which is degraded during the late stage of autophagy, and negative correlates with autophagic activation [28] . As shown, up-regulation of microRNA-155 resulted in reduction of P62/SQSTM1 protein levels ( Fig. 2E and I, *P<0.05, **P<0.01). In addition, cells were treated with bafilomycin α1 (BAF) which could prevent autophagolysosome formation [30] . BAF stimulation caused significant up-regulation of LC3-II and P62/SQSTM1 protein levels in microRNA-155 mimics-transfected cells (Fig. 2E, H and I, *P<0.05, **P<0.01). Therefore, these results indicates that microRNA-155 promotes both accumulation of autophagosome and autophagic degradation, suggesting the autophagic activation in EA.hy926 endothelial cells.
Inhibition of MicroRNA-155 suppresses ox-LDL-induced autophagy in endothelial cells
To further explore the physiological relevance of microRNA-155 in EA.hy926 endothelial cells, we inhibited endogenous microRNA-155 expression under ox-LDL stress (80ug/ml), then repeated LC3 and P62/SQSTM1 protein assays by western blot. As shown, ox-LDL increased LC3-II and decreased P62/SQSTM1 levels, reflecting an enhancement of autophagic activation. However, inhibition of microRNA-155 significantly reduced P62/SQSTM1 degradation and LC3-II levels in cells treated with ox-LDL (Fig. 3A-B , **P<0.01, ***P<0.001). Hence, these data demonstrates that inhibition of microRNA-155 could suppress ox-LDLinduced autophagic activation.
MicroRNA-155 directly interacts with 3'-UTR of Rheb
Ras homolog enriched in brain (Rheb) has been reported to be a direct target of microRNA-155 [23] . To understand the biological role that underlies the interaction As shown, up-regulation of microRNA-155 led to a significant decrease, while inhibition of it led to an obvious increase of Rheb protein levels, relative to the control group (Fig. 4C-D , *P<0.05, **P<0.01). Thus, microRNA-155 could directly target Rheb.
MicroRNA-155 induces autophagy via suppression of Rheb/mTOR pathway
We considered whether knocking down of Rheb expression could phenocopy the effect of microRNA-155 on autophagy. We transfected small interfering RNA (siRNA)-Rheb or siRNA-NC into EA.hy926 endothelial cells. By qRT-PCR and western blot assays, we validated that expression of Rheb in siRheb group was lower than in siRNA-NC group (Fig. 5A-C , **P<0.01). Similar to microRNA-155, depletion of endogenous Rheb induced a significant increase of LC3-II and a reduction of P62 protein levels (Fig. 5B-C, *P<0 .05, ***P<0.001). Then, we co-transfected microRNA-155 mimic and plasmid into endothelial cells. The pcDNA-Rheb plasmid was designed to carry the open reading frame of human Rheb without 3'-UTR. The empty pcDNA was a control. As shown, LC3-II and Beclin-1 levels were lowered in cells co-transfected with microRNA-155 mimics and pcDNA-Rheb plasmid (Fig. 5D-E, *P<0 .05, **P<0.01, ***P<0.001). The results suggest that depletion of endogenous Rheb induces autophagy, whereas over-expression of Rheb could overcome microRNA-155 induced autophagy in endothelial cells.
Furthermore, we found that depletion of endogenous Rheb also attenuated the expression of mammalian target of rapamycin (mTOR) at both transcription and translation levels, which is known as a central negative regulator of autophagy (Fig. 5A-C, *P<0.05) . We 
Cellular Physiology
transfected cells with microRNA-155 inhibitor or inhibitor-NC under ox-LDL stress, then checked the protein levels of phospho-mTOR (S2481) and its downstream targets phosphoP70S6kinase (S731), phospho-4EBP1 (T37/46) and phospho-S6 (S235/236) by western blot. We showed that ox-LDL induced down-regulation of p-mTOR, p-P70S6 kinase, p-4EBP1 and p-S6 proteins. But, the amounts of these proteins were increased while microRNA-155 was inhibited. More intriguing results, when we used rapamycin to attenuate mTOR activity in microRNA-155 inhibited cells, the p-P70S6 kinase, p-4EBP1, p-S6 levels are significantly decreased again (Fig. 5F -G, **P<0.01, ***P<0.001). In the light of the above results, we indicate that ox-LDL-induced microRNA-155 targets the Rheb/mTOR signaling pathway, and enhances the autophagic activation.
MicroRNA-155 attenuates cell viability and induces apoptosis under ox-LDL stress
As autophagy is implicated in cellular survival to a large extent, we assumed that microRNA-155 might also protect cells from injury. Contrary to our expectation, we observed that microRNA-155 attenuated cell viability and significantly increased the average apoptotic cell fractions, especially under ox-LDL (80ug/ml) stress (Fig. 6A -E *P<0.05, **P<0.01, ***P<0.001). Whereas, inhibition of microRNA-155 improved cell viability and retarded apoptosis (Fig.6A , C and G *P<0.05, **P<0.01, ***P<0.001). Furthermore, cells were pretreated with a classical autophagy inhibitor-3-MA [31] (5nM) for 4h, then transfected with microRNA-155 mimics or NC-mimics. Interestingly, inhibition of autophagy increased the apoptotic cell fractions in both microRNA-155 and NC-mimics transfected cells, but microRNA-155 could reduce the apoptotic effect caused by 3-MA and improve cell viability (Fig. 6A, B and F *P<0.05, **P<0.01, ***P<0.001). These collective results demonstrate that microRNA-155 plays different roles in diverse circumstances, and might act as a possible link-bridge between autophagy and apoptosis.
Discussion
Accumulating evidence indicates that endothelial dysfunction drives initiation, development and even rupture of atherosclerotic plaques [32] . Therefore, it is necessary to focus on the potential targets of endothelial dysfunction, which in turn would provide novel prevention and treatment strategies [33] .
In recent years, microRNAs have been of great concern in atherosclerosis [13, 34] . It is imperative to illustrate that microRNA-155 impacts and regulates development of atherogenesis. Besides, previous findings coincide with our results which identified that microRNA-155 is significantly up-regulated following exposure of cells to ox-LDL, and correlates with atherosclerosis [35, 36] . Muller et al. observed that ox-LDL intensifies autophagy in endothelial cells compared with cells treated with native LDL or negative control group [37] . So, we hypothesized that microRNA-155 was involved in the process of endothelial autophagy. Our results showed that ectopic high expression of microRNA-155 increases both formation and degradation of autolysosome in EA.hy926 endothelial cells, and vice versa when inhibited microRNA-155. It is implied that ox-LDL-induced microRNA-155 acts as a potent activator of autophagy in endothelial cells.
We then predicted and confirmed Rheb, a small G protein, as a target of microRNA-155 in oxLDL-induced endothelial cells. Previous studies have demonstrated that over-expression of Rheb in mammalian cells directly leads to mTOR activation [38] . As an upstream regulator of mTOR, Rheb is regulated by kinases, such as Akt, AMP-activated protein kinase (AMPK), and glycogen synthase kinase-3, which control Rheb through modulating the heterodimer consisting of tuberous sclerosis 1/tuberous sclerosis 2 complex (TSC1/TSC2) [39] . The mTOR signaling integrates and transmits signals to regulate cell growth, metabolism, ribosomal biogenesis, as well as autophagy [40, 41] Attention must be paid on the effects of autophagy on cellular homeostasis. It is predominantly recognized as a pro-survival pathway during cellular stress in plaque formation [44] . For instance, apoptosis of statin-induced smooth muscle cells (SMCs) could be partially rescued by autophagy inducer [45] . Likewise, the protective role of verapamil stereoisomers in promoting neointima formation is directly associated with the onset of autophagy following vascular injury [46] . On the contrary, several lines of evidence indicated that autophagy plays a harmful role in atherosclerosis. Inhibition of autophagy stimulates nitric oxide production and protects endothelial function [47] . Autophagic death of SMCs results in plaque destabilization owing to the reduced synthesis of collagen and thinning of the fibrous cap [48] . In Ischemia/Reperfusion injury, iNOS induces vascular endothelial cell migration and apoptosis via autophagy [49] . Recently, microRNAs have been focused on the crosstalk between apoptosis and autophagy by the action of some common proteins, such as Beclin-1, p53 and DAPK [50] [51] [52] [53] . Here we discovered that microRNA-155 induces not only autophagy but also apoptosis in endothelial cells, while inhibition of it alleviates ox-LDLinduced apoptosis and consecutively improves cell viability rate. Whereas, microRNA-155 reduces the apoptotic effect caused by 3-MA and enhances cell viability. Though, statistically significant does not necessarily mean biologically relevant, the results could still suggest that microRNA-155 has diverse roles in varied circumstances, and might act as a possible link-bridge between autophagy and apoptosis.
Autophagic activity represents a prospective future therapeutic target in atherosclerotic diseases [54] . However, despite the discovery of many specific genes and the dissection of signaling pathways involved in the regulation of autophagy provided therapeutic approaches which are highly limited. With the above findings microRNA-155 would be one of the potential targets through co-intervention of autophagy and apoptosis in endothelial cells. Indeed, the existed achievement is far from enough, and exploring the effect of microRNA-155 on autophagy in vivo would be necessary in our future research. In spite of all the valuable knowledge, additional studies on microRNA-155 are needed to be clarified in the pathological mechanism of atherosclerosis.
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